Lewis R Roberts, MB ChB, PhD - Mayo Clinic - Professor of Medicine

Lewis R Roberts

MB ChB, PhD

Mayo Clinic

Professor of Medicine

Rochester, Minnesota | United States

Main Specialties: Gastroenterology

Additional Specialties: Gastroenterology and Hepatology

Lewis R Roberts, MB ChB, PhD - Mayo Clinic - Professor of Medicine

Lewis R Roberts

MB ChB, PhD

Introduction

Primary Affiliation: Mayo Clinic - Rochester, Minnesota , United States

Specialties:

Additional Specialties:

Publications

144Publications

4220Reads

1712Profile Views

2075PubMed Central Citations

Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy.

Clin Gastroenterol Hepatol 2017 Jun 30;15(6):927-933. Epub 2016 Dec 30.

Division of Endocrinology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.11.038DOI Listing
June 2017
22 Reads
2 Citations
7.900 Impact Factor

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.

Clin Gastroenterol Hepatol 2017 May 21;15(5):767-775.e3. Epub 2016 Dec 21.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.11.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401787PMC
May 2017
16 Reads
3 Citations
7.900 Impact Factor

MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings.

Magn Reson Imaging 2017 Apr 11;37:41-45. Epub 2016 Nov 11.

Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mri.2016.11.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587120PMC
April 2017
17 Reads
4 Citations
2.022 Impact Factor

Reply.

Hepatology 2017 04 29;65(4):1422-1423. Epub 2016 Dec 29.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28922DOI Listing
April 2017
7 Reads
11.055 Impact Factor

Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.

Epigenetics 2017 03 6;12(3):215-225. Epub 2017 Jan 6.

a Department of Molecular Pharmacology and Experimental Therapeutics , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15592294.2016.1277297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406211PMC
March 2017
14 Reads
4.780 Impact Factor

High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver.

Epigenetics 2017 01 18;12(1):55-69. Epub 2016 Nov 18.

a Department of Molecular Pharmacology and Experimental Therapeutics , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15592294.2016.1261239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270632PMC
January 2017
39 Reads
5 Citations
4.780 Impact Factor

Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.

Cancer 2017 Jan 29;123(1):81-89. Epub 2016 Aug 29.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161593PMC
January 2017
13 Reads
2 Citations
4.890 Impact Factor

Reply.

Hepatology 2016 12 18;64(6):2258-2259. Epub 2016 Oct 18.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28807DOI Listing
December 2016
10 Reads
11.055 Impact Factor

Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.

Int J Oncol 2016 Nov 2;49(5):2037-2045. Epub 2016 Sep 2.

College of Pharmacy, Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2016.3677DOI Listing
November 2016
109 Reads
4 Citations
3.025 Impact Factor

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Am J Gastroenterol 2016 11 16;111(11):1573-1580. Epub 2016 Aug 16.

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2016.330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040826PMC
November 2016
55 Reads
9 Citations
10.760 Impact Factor

Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.

J Hepatol 2016 10 5;65(4):859-860. Epub 2016 Jul 5.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.06.023DOI Listing
October 2016
26 Reads
19 Citations
11.340 Impact Factor

Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.

Chin Clin Oncol 2016 Oct;5(5):61

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.10.09DOI Listing
October 2016
27 Reads
8 Citations

Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

J Surg Oncol 2016 Sep 20;114(4):475-82. Epub 2016 Jul 20.

Section of Hepatobiliary and Pancreatic Surgery, Division of Subspecialty General Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038702PMC
September 2016
33 Reads
4 Citations
3.244 Impact Factor

Aspirin use and the risk of cholangiocarcinoma.

Hepatology 2016 09 26;64(3):785-96. Epub 2016 Apr 26.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995727PMC
September 2016
51 Reads
11 Citations
11.055 Impact Factor

Khat chewing and cirrhosis in Somaliland: Case series.

Afr J Prim Health Care Fam Med 2016 Jul 28;8(1):e1-4. Epub 2016 Jul 28.

Mayo Clinic, Minnesota.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992185PMC
http://dx.doi.org/10.4102/phcfm.v8i1.1124DOI Listing
July 2016
8 Reads
2 Citations

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

J Clin Oncol 2016 06 11;34(16):1898-904. Epub 2016 Apr 11.

Roongruedee Chaiteerakij and Lewis R. Roberts, Mayo Clinic College of Medicine and Mayo Clinic Cancer Center; Gloria M. Petersen, William R. Bamlet, Kari G. Chaffee, David B. Zhen, Patrick A. Burch, Emma R. Leof, and Ann L. Oberg, Mayo Clinic, Rochester, MN; Roongruedee Chaiteerakij, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; and David B. Zhen, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.3511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966342PMC
June 2016
40 Reads
12 Citations
18.430 Impact Factor

Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.

Gastrointest Endosc 2016 Jun 10;83(6):1228-35. Epub 2015 Dec 10.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, and Mayo Clinic Cancer Center, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2015.11.037DOI Listing
June 2016
69 Reads
5.370 Impact Factor

Erratum to "Clinical implications of basic research in hepatocellular carcinoma" [J Hepatol 2016;64:736-745].

J Hepatol 2016 Jun 22;64(6):1462. Epub 2016 Mar 22.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.02.036DOI Listing
June 2016
13 Reads
11.340 Impact Factor

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances.

F1000Res 2016 12;5. Epub 2016 May 12.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.6946.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870992PMC
May 2016
13 Reads
13 Citations

Biomarkers for Hepatocellular Carcinoma.

Authors:
Lewis R Roberts

Gastroenterol Hepatol (N Y) 2016 Apr;12(4):252-5

Professor of Medicine Department of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872856PMC
April 2016
27 Reads
1 Citation

Biomarkers for hepatocellular carcinoma.

Authors:
Lewis R Roberts

Clin Adv Hematol Oncol 2016 Apr;14(4):223-34

Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
April 2016
7 Reads

Clinical implications of basic research in hepatocellular carcinoma.

J Hepatol 2016 Mar 9;64(3):736-45. Epub 2015 Oct 9.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039166PMC
March 2016
9 Reads
7 Citations
11.340 Impact Factor

Metformin does not improve survival of cholangiocarcinoma patients with diabetes.

Hepatology 2016 Feb 7;63(2):667-8. Epub 2015 May 7.

Division of Gastroenterology and Hepatology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27821DOI Listing
February 2016
8 Reads
3 Citations
11.055 Impact Factor

An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.

Gastroenterology 2015 Dec 29;149(7):1813-1824.e1. Epub 2015 Aug 29.

Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.08.046DOI Listing
December 2015
40 Reads
7 Citations
16.720 Impact Factor

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.

Sci Rep 2015 Oct 1;5:14752. Epub 2015 Oct 1.

Genetics Program, Michigan State University, 567 Wilson Road, Rm 2240E, East Lansing, Michigan 48824, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep14752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589791PMC
October 2015
18 Reads
30 Citations
5.080 Impact Factor

Biphenotypic hepatic tumors: imaging findings and review of literature.

Abdom Imaging 2015 Oct;40(7):2293-305

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-015-0433-9DOI Listing
October 2015
17 Reads
2 Citations
1.730 Impact Factor

Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.

Cancer Med 2015 Oct 15;4(10):1599-602. Epub 2015 Aug 15.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, and Mayo Clinic Cancer Center, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618630PMC
October 2015
25 Reads
1 Citation

Short and long telomeres increase risk of amnestic mild cognitive impairment.

Mech Ageing Dev 2014 Nov-Dec;141-142:64-9. Epub 2014 Oct 22.

Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mad.2014.10.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310802PMC
September 2015
24 Reads
5 Citations
3.400 Impact Factor

Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis.

Mayo Clin Proc 2015 Sep 3;90(9):1196-206. Epub 2015 Aug 3.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567441PMC
September 2015
22 Reads
6.262 Impact Factor

The role of hepatic resection in the treatment of hepatocellular cancer.

Hepatology 2015 Aug 20;62(2):440-51. Epub 2015 Mar 20.

University of Toronto and University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27745DOI Listing
August 2015
48 Reads
34 Citations
11.055 Impact Factor

Ectopic Gallbladder.

Clin Gastroenterol Hepatol 2015 Jul 6;13(7):e69. Epub 2015 Jan 6.

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2014.12.028DOI Listing
July 2015
24 Reads
7.900 Impact Factor

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

Mod Pathol 2015 Jun 20;28(6):822-9. Epub 2015 Feb 20.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2015.4DOI Listing
June 2015
40 Reads
20 Citations
6.190 Impact Factor

Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.

PLoS One 2014 7;9(4):e92273. Epub 2014 Apr 7.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092273PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977817PMC
June 2015
18 Reads
12 Citations
3.234 Impact Factor

Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Curr Hepatol Rep 2015 Jun;14(2):128-138

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11901-015-0261-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551404PMC
June 2015
33 Reads
2 Citations

Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.

Clin Liver Dis 2015 May;19(2):277-94

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2015.01.011DOI Listing
May 2015
10 Reads
3 Citations
3.660 Impact Factor

Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma.

Curr Opin Gastroenterol 2015 May;31(3):264-8

aDivision of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona bDepartment of Molecular Medicine cDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0000000000000171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750878PMC
May 2015
39 Reads
6 Citations
4.290 Impact Factor

Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.

Liver Transpl 2015 May;21(5):599-606

Division of Gastroenterology and Hepatology, Mayo Clinic Cancer Center, Rochester, MN; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lt.24117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490162PMC
May 2015
37 Reads
13 Citations
4.241 Impact Factor

Unique genomic profile of fibrolamellar hepatocellular carcinoma.

Gastroenterology 2015 Apr 31;148(4):806-18.e10. Epub 2014 Dec 31.

HCC Translational Research Laboratory, Barcelona Clinic Liver Cancer Group, Liver Unit, Pathology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, CIBERehd, Hospital Clínic, Universitat de Barcelona, Catalonia, Spain; Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Recanati/Miller Transplantation Institute; Department of Pathology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.12.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521774PMC
April 2015
50 Reads
23 Citations
16.720 Impact Factor

Update on biomarkers of hepatocellular carcinoma.

Clin Gastroenterol Hepatol 2015 Feb 23;13(2):237-45. Epub 2013 Nov 23.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.10.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032371PMC
February 2015
12 Reads
26 Citations
7.900 Impact Factor

Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors.

Hepatology 2015 Jan 19;61(1):361-74. Epub 2014 Sep 19.

GI Research Unit and Cancer Cell Biology Program, Mayo Clinic, Rochester, MN; Department of Hepatobillary Surgery, the 1st Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262723PMC
January 2015
56 Reads
12 Citations
11.055 Impact Factor

A new clinically based staging system for perihilar cholangiocarcinoma.

Am J Gastroenterol 2014 Dec 11;109(12):1881-90. Epub 2014 Nov 11.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Mayo Clinic Cancer Center, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2014.327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341961PMC
December 2014
40 Reads
22 Citations
10.760 Impact Factor

Rethinking cancer immunotherapy: Using advanced cancer genetics in immune-mediated eradication of gastrointestinal cancers.

Hepatology 2014 Dec 30;60(6):2121-4. Epub 2014 Oct 30.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27442DOI Listing
December 2014
19 Reads
3 Citations
11.055 Impact Factor

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Hepatology 2014 Dec 31;60(6):2008-16. Epub 2014 Jul 31.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.27199
Publisher Site
http://dx.doi.org/10.1002/hep.27199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218882PMC
December 2014
17 Reads
24 Citations
11.055 Impact Factor

Metformin does not improve survival in patients with hepatocellular carcinoma.

World J Gastroenterol 2014 Nov;20(42):15750-5

Mamatha Bhat, Roongruedee Chaiteerakij, Ju Dong Yang, Nasra H Giama, Gregory J Gores, Lewis R Roberts, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55902, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i42.15750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229540PMC
November 2014
35 Reads
5 Citations
2.370 Impact Factor

Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.

Oncotarget 2014 Oct;5(19):9425-43

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253444PMC
http://dx.doi.org/10.18632/oncotarget.2444DOI Listing
October 2014
88 Reads
17 Citations
6.360 Impact Factor

Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.

Cardiovasc Intervent Radiol 2014 Oct 23;37(5):1343-51. Epub 2014 Jan 23.

Medical Scientist Training Program, College of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-013-0828-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108574PMC
October 2014
23 Reads
9 Citations
1.970 Impact Factor

Liver masses: a clinical, radiologic, and pathologic perspective.

Clin Gastroenterol Hepatol 2014 Sep 18;12(9):1414-29. Epub 2013 Sep 18.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959647PMC
September 2014
6 Reads
8 Citations
7.900 Impact Factor

Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.

J Biol Chem 2014 Aug 27;289(33):22835-49. Epub 2014 Jun 27.

From the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.563064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132787PMC
August 2014
34 Reads
13 Citations
4.573 Impact Factor

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.

Hum Pathol 2014 Aug 13;45(8):1630-8. Epub 2014 Apr 13.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.03.014DOI Listing
August 2014
29 Reads
33 Citations
2.770 Impact Factor

Treating hepatitis C in lower-income countries.

N Engl J Med 2014 May 10;370(20):1869-71. Epub 2014 Apr 10.

From the Division of Gastroenterology and Hepatology (C.R.J., M.H.N.) and the Department of Medicine (C.R.J., M.B., M.H.N.), Stanford University Medical Center; and the Center for Innovation in Global Health, Stanford University (M.B.) - both in Stanford, CA; and the Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN (L.R.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1400160DOI Listing
May 2014
15 Reads
30 Citations
55.873 Impact Factor

Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo study.

Lasers Surg Med 2014 Apr 18;46(4):290-301. Epub 2014 Mar 18.

Medical Scientist Training Program, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lsm.22231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269152PMC
April 2014
8 Reads
6 Citations
2.620 Impact Factor

Fibroblast growth factor signaling in liver carcinogenesis.

Hepatology 2014 Mar;59(3):1166-73

View Article

Download full-text PDF

Source
March 2014
32 Reads
17 Citations
11.055 Impact Factor

Chemopreventive strategies in hepatocellular carcinoma.

Nat Rev Gastroenterol Hepatol 2014 Jan 13;11(1):45-54. Epub 2013 Aug 13.

Division of Gastroenterology and Hepatology, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2013.143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334449PMC
January 2014
15 Reads
58 Citations
12.610 Impact Factor

Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Cancer Cytopathol 2013 Dec 9;121(12):708-17. Epub 2013 Jul 9.

Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21331DOI Listing
December 2013
36 Reads
10 Citations
3.354 Impact Factor

Reply: To PMID 23055147.

Hepatology 2013 Nov;58(5):1863

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26441DOI Listing
November 2013
16 Reads
11.055 Impact Factor

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.

Hum Pathol 2013 Jul 4;44(7):1216-22. Epub 2013 Feb 4.

Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.11.006DOI Listing
July 2013
36 Reads
45 Citations
2.770 Impact Factor

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: insights from next generation DNA sequencing.

J Hepatol 2013 May 6;58(5):1042-4. Epub 2012 Dec 6.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2012.11.046DOI Listing
May 2013
5 Reads
1 Citation
11.340 Impact Factor

Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis.

PLoS Genet 2013 Apr 4;9(4):e1003441. Epub 2013 Apr 4.

Department of Anatomy and Cell Biology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.pgen.1003441
Publisher Site
http://dx.doi.org/10.1371/journal.pgen.1003441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616914PMC
April 2013
65 Reads
30 Citations

The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.

Genes Chromosomes Cancer 2013 Mar 29;52(3):225-36. Epub 2012 Oct 29.

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889201PMC
March 2013
14 Reads
16 Citations
4.041 Impact Factor

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.

Hepatology 2013 Feb 12;57(2):648-55. Epub 2012 Dec 12.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565026PMC
February 2013
30 Reads
34 Citations
11.055 Impact Factor

AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.

Cardiovasc Intervent Radiol 2013 Feb 25;36(1):198-203. Epub 2012 Aug 25.

Medical Scientist Training Program, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-012-0466-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904804PMC
February 2013
7 Reads
10 Citations
1.970 Impact Factor

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Cancer Res 2013 Jan 5;73(2):897-907. Epub 2012 Dec 5.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549008PMC
January 2013
77 Reads
36 Citations
9.330 Impact Factor

Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas.

Carcinogenesis 2012 Dec 12;33(12):2568-77. Epub 2012 Sep 12.

State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, PR China.

View Article

Download full-text PDF

Source
http://carcin.oxfordjournals.org/content/33/12/2568.full.pdf
Web Search
http://www.carcin.oxfordjournals.org/cgi/doi/10.1093/carcin/
Publisher Site
http://dx.doi.org/10.1093/carcin/bgs287DOI Listing
December 2012
44 Reads
12 Citations
5.334 Impact Factor

Immunotherapeutic approaches to hepatocellular carcinoma treatment.

Liver Cancer 2012 Nov;1(3-4):226-37

Division of Gastroenterology and Hepatology, College of Medicine College of Medicine, Mayo Clinic, Minnesota, USA ; Department of Immunology, Mayo Graduate and Medical Schools College of Medicine, Mayo Clinic, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000343837DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760468PMC
November 2012
35 Reads
19 Citations

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.

Hum Pathol 2012 Oct 12;43(10):1552-8. Epub 2012 Apr 12.

Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.12.007DOI Listing
October 2012
35 Reads
53 Citations
2.770 Impact Factor

Model to estimate survival in ambulatory patients with hepatocellular carcinoma.

Hepatology 2012 Aug 2;56(2):614-21. Epub 2012 Jul 2.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564594PMC
August 2012
33 Reads
16 Citations
11.055 Impact Factor

Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.

Am J Gastroenterol 2012 Aug 3;107(8):1256-62. Epub 2012 Jul 3.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2012.173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654834PMC
August 2012
43 Reads
14 Citations
10.760 Impact Factor

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

Gastroenterology 2012 Apr 13;142(4):1021-1031.e15. Epub 2011 Dec 13.

Laboratory of Experimental Carcinogenesis, National Institutes of Health, Bethesda, Maryland 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2011.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413201PMC
April 2012
34 Reads
99 Citations
16.720 Impact Factor

Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.

Breast Cancer Res 2012 Mar 12;14(2):R43. Epub 2012 Mar 12.

Department of Experimental Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446377PMC
March 2012
31 Reads
10 Citations

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.

Hepatology 2012 Feb 19;55(2):465-75. Epub 2011 Dec 19.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268937PMC
February 2012
6 Reads
69 Citations
11.055 Impact Factor

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma.

J Hepatol 2012 Feb 29;56(2):486-7. Epub 2011 Sep 29.

Fundación Valle Del Lili, Cali, Colombia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2011.07.033DOI Listing
February 2012
7 Reads
11.340 Impact Factor

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.

J Hepatol 2012 Jan 9;56(1):176-83. Epub 2011 Aug 9.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2011.07.013DOI Listing
January 2012
16 Reads
20 Citations
11.340 Impact Factor

Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.

Mayo Clin Proc 2012 Jan;87(1):9-16

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2011.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538386PMC
January 2012
25 Reads
14 Citations
6.262 Impact Factor

Genes associated with recurrence of hepatocellular carcinoma: integrated analysis by gene expression and methylation profiling.

J Korean Med Sci 2011 Nov 27;26(11):1428-38. Epub 2011 Oct 27.

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3346/jkms.2011.26.11.1428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207045PMC
November 2011
25 Reads
16 Citations
1.253 Impact Factor

Occult hepatitis B virus infection: bit player or role player?

Hepatology 2011 Sep;54(3):760-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24528DOI Listing
September 2011
38 Reads
3 Citations

Rare distant skeletal muscle metastasis from hilar cholangiocarcinoma: report of a case.

J Gastrointest Cancer 2011 Sep;42(3):171-3

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-010-9237-xDOI Listing
September 2011
5 Reads
3 Citations

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Hepatology 2011 Sep 8;54(3):940-8. Epub 2011 Aug 8.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253343PMC
September 2011
36 Reads
25 Citations

Factors that affect risk for hepatocellular carcinoma and effects of surveillance.

Clin Gastroenterol Hepatol 2011 Jul 1;9(7):617-23.e1. Epub 2011 Apr 1.

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2011.03.027DOI Listing
July 2011
17 Reads
1 Citation

Pharmacogenetics in Ghana.

Ghana Med J 2011 Jun;45(2):43-4

Fundacion Valle Del Lili, Cali, Colombia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158538PMC
June 2011
11 Reads

Telomerase mutation: a genetic risk factor for cirrhosis.

Hepatology 2011 May;53(5):1430-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24304DOI Listing
May 2011
15 Reads
5 Citations

The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Semin Cancer Biol 2011 Feb 12;21(1):35-43. Epub 2010 Oct 12.

Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2010.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050428PMC
February 2011
31 Reads
68 Citations

Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.

Genes Chromosomes Cancer 2011 Feb;50(2):122-35

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253341PMC
February 2011
44 Reads
16 Citations

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.

Clin Gastroenterol Hepatol 2011 Jan 8;9(1):64-70. Epub 2010 Sep 8.

Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2010.08.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951426PMC
January 2011
36 Reads
28 Citations

Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies.

Gut Liver 2010 Dec 17;4(4):537-42. Epub 2010 Dec 17.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5009/gnl.2010.4.4.537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021612PMC
December 2010
41 Reads
2 Citations

Epidemiology and management of hepatocellular carcinoma.

Infect Dis Clin North Am 2010 Dec;24(4):899-919, viii

Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.idc.2010.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949429PMC
December 2010
20 Reads
32 Citations

miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.

Biochem Biophys Res Commun 2010 Dec 3;403(1):120-5. Epub 2010 Nov 3.

Department of Surgery, Ohio State University Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2010.10.130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039123PMC
December 2010
43 Reads
42 Citations

Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.

Liver Int 2010 Nov 8;30(10):1522-8. Epub 2010 Sep 8.

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2010.02336.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042145PMC
November 2010
35 Reads
7 Citations

Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.

J Mol Diagn 2010 Nov 23;12(6):780-6. Epub 2010 Sep 23.

Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/jmoldx.2010.100016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963905PMC
November 2010
40 Reads
11 Citations

A necrotic liver mass.

Gastroenterology 2010 Sep 30;139(3):e6-7. Epub 2010 Jul 30.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2009.10.064DOI Listing
September 2010
11 Reads

Evaluation of a focal lesion in the liver. answer to the clinical challenges and images in GI question: image 3: Focal fatty infiltration.

Gastroenterology 2010 Aug 26;139(2):e10-1. Epub 2010 Jun 26.

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2009.09.072DOI Listing
August 2010
9 Reads
2 Citations

Hepatocellular carcinoma: A global view.

Nat Rev Gastroenterol Hepatol 2010 Aug 13;7(8):448-58. Epub 2010 Jul 13.

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2010.100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926946PMC
August 2010
8 Reads
1 Citation

Hepatic adenomas associated with anti-epileptic drugs: a case series and imaging review.

Abdom Imaging 2010 Apr 13;35(2):208-11. Epub 2009 Mar 13.

Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-009-9500-4DOI Listing
April 2010
13 Reads

Liver transplantation after radioembolization in a patient with unresectable HCC.

Nat Rev Gastroenterol Hepatol 2009 Nov;6(11):679-83

Department of Medicine, Universidad de Guadalajara, Guadalajara, México.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2009.165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904913PMC
November 2009
30 Reads
1 Citation

Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.

J Vasc Interv Radiol 2009 Nov;20(11):1460-3

Department of Radiology, Division of Vascular and Interventional Radiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2009.07.033DOI Listing
November 2009
10 Reads
1 Citation

The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis.

J Gastrointest Cancer 2008 17;39(1-4):149-58. Epub 2009 Apr 17.

Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-009-9058-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925118PMC
September 2009
16 Reads
22 Citations

Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.

J Hepatol 2009 Jun 9;50(6):1112-21. Epub 2009 Mar 9.

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2008.12.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756527PMC
June 2009
23 Reads
9 Citations

PDGFRalpha: a new therapeutic target in the treatment of hepatocellular carcinoma?

Expert Opin Ther Targets 2009 Apr;13(4):443-54

Miles and Shirley Fiterman Center for Digestive Diseases College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728220902719233 DOI Listing
April 2009
19 Reads
13 Citations

A new, effective and high-yield approach for identifying liver tumor suppressors.

Genome Med 2009 Feb 26;1(2):26. Epub 2009 Feb 26.

Department of Internal Medicine, McLaren Regional Medical Center, 401 S Ballenger Highway, Flint, Michigan 48532, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664959PMC
February 2009
7 Reads
1 Citation

Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Future Oncol 2008 Dec;4(6):803-14

Center for Basic Research in Digestive Diseases, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine and Mayo Clinic Cancer Center, 200 First Street, SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.4.6.803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042146PMC
December 2008
29 Reads
17 Citations

Clinical challenges and images in GI. Radiation cholecystitis.

Gastroenterology 2008 Jul 13;135(1):18, 328. Epub 2008 Jun 13.

Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine and Mayo Clinic, Cancer Center, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.06.008DOI Listing
July 2008
8 Reads

Sorafenib in liver cancer--just the beginning.

Authors:
Lewis R Roberts

N Engl J Med 2008 Jul;359(4):420-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe0802241DOI Listing
July 2008
11 Reads
16 Citations

Diagnosis and management of cholangiocarcinoma.

Curr Gastroenterol Rep 2008 Feb;10(1):43-52

Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
February 2008
24 Reads
6 Citations

Treatment options for hepatocellular carcinoma.

Expert Rev Gastroenterol Hepatol 2008 Feb;2(1):81-92

Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2.1.81DOI Listing
February 2008
34 Reads
5 Citations

Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.

Liver Int 2008 Jan 21;28(1):12-27. Epub 2007 Nov 21.

Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2007.01624.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904912PMC
January 2008
25 Reads
11 Citations

Casting a wider net: improving access to medical literature in developing countries.

Mayo Clin Proc 2007 Jul;82(7):846-8

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, Minn 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/82.7.846DOI Listing
July 2007
31 Reads

Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.

Clin Gastroenterol Hepatol 2007 Jun;5(6):743-8

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2007.02.021DOI Listing
June 2007
18 Reads
8 Citations

Treatment options for hepatobiliary and pancreatic cancer.

Mayo Clin Proc 2007 May;82(5):628-37

Division of Medical Oncology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/82.5.628DOI Listing
May 2007
38 Reads
14 Citations

Top co-authors

Roongruedee Chaiteerakij
Roongruedee Chaiteerakij

Chulalongkorn University

23
Gregory J Gores
Gregory J Gores

Mayo Clinic

23
Ju Dong Yang
Ju Dong Yang

Mayo Clinic College of Medicine

16
Terry M Therneau
Terry M Therneau

Mayo Clinic

14
Catherine D Moser
Catherine D Moser

Mayo Clinic

13
William S Harmsen
William S Harmsen

Mayo Clinic

10
Benjamin R Kipp
Benjamin R Kipp

Mayo Clinic

9
Kevin C Halling
Kevin C Halling

Mayo Clinic

9
Sudhakar K Venkatesh
Sudhakar K Venkatesh

Mayo Clinic

7
Scott M Thompson
Scott M Thompson

University of Maryland School of Medicine

7